Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Scailyte uses AI and single-cell analysis to discover molecular biomarkers that enable patient stratification and companion diagnostics. The company applies its proprietary ScaiVision platform to…

Scailyte uses AI and single-cell analysis to discover molecular biomarkers that enable patient stratification and companion diagnostics. The company applies its proprietary ScaiVision platform to…
Founded: 2017 (ETH Zürich spin-off)
Headquarters: Basel, Switzerland
Focus: AI-driven single-cell and multimodal omics biomarkers for diagnostics and CDx
Proprietary platform: ScaiVision (explainable AI for single-cell & multimodal data)
Latest disclosed funding: Series A extended; total funding reported ≈ $15.5M (last close 2023-12-04)
Biomarker discovery and diagnostic/companion diagnostic development using single-cell and multimodal omics data
2017
Biotechnology
USD 8,000,000 (Series A extension announced by company)
Company announced extension of Series A to USD 8 million; third-party profiles list total funding ≈ $15.5M
Pre-Series A financing announced with 4FO named as a lead investor
“4FO Ventures; other reported investors include Swisscom Ventures, Mirabaud, Verve Ventures, Hemex, Innosuisse, MassChallenge, Venture Kick”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,300+
New This Week